 |
 |
Dear CEBM listserv colleagues, Building on the spirit of clinical trial data transparency, the RxISK<https://www.rxisk.org/Default.aspx>organization is running a very specific petition <http://tinyurl.com/n8j3yjv> to help the global efforts on transparency. RxISK and its growing supporters are calling AbbVie and InterMune to drop their recent outrageous legal action against the European Medicines Agency (EMA), where these two companies defined drug hazards as "commercially confidential" information (!). I'm sure everyone on the CEBM listserv is familiar with this huge transparency setback and its consequences to global patient safety and transparency initiatives. In case you'd like more information, you can find it here<http://www.bloomberg.com/news/2013-03-11/abbvie-sues-eu-regulator-to-block-clinical-trial-data-release.html>and here <http://davidhealy.org/abbvie/>. Please read the recent JAMA letter by Peter Doshi (attached), detailing further this unfortunate backward step in transparency. *Anybody taking any kind of medication has a right to know all about their medication. Drug hazards cannot be defined as "trade secrets". Please give your voice of support to the <https://www.change.org/petitions/richard-gonzalez-of-abbvie-and-daniel-welch-of-intermune-drop-your-legal-action-blocking-access-to-ema-clinical-trial-data> **RxISK initiative<https://www.change.org/petitions/richard-gonzalez-of-abbvie-and-daniel-welch-of-intermune-drop-your-legal-action-blocking-access-to-ema-clinical-trial-data>in its effort to stop the legal action against EMA and contribute to global patient safety and better medicines.* * Please forward this email to anybody who would be interested in supporting global patient safety efforts. * Thank you for your support! Sincerely, Lejla -- *Lejla Halilovic*, BSc., Hon. O.C.G.C. (Pharm. Reg. Affairs) *e.* [log in to unmask] *LinkedIn.* http://ca.linkedin.com/in/lejlahalilovic